News | Press Releases

For Immediate Release Contact marketingcommunications@us.medical.canon

June 12, 2017

Toshiba Medical’s Premium Ultrasound Platform Enables Fast and Safe Liver Imaging

UC San Diego Health Uses the Aplio i-series’ Contrast-Enhanced Ultrasound Package

UC San Diego Health is using Toshiba Medical’s Aplio i-series’ imaging resolution and penetration, and comprehensive contrast-enhanced ultrasound imaging and quantification package, to assess perfusion dynamics in the liver and help improve hepatocellular carcinoma surveillance results.

TUSTIN, Calif., June 12, 2017 – Physicians now have the powerful imaging technology they need for fast, safe and reliable evaluation of liver lesions with the premium AplioTM i-series ultrasound platform from Toshiba Medical, a Canon Group company. With the recent expansion of LI-RADS® (Liver Imaging Reporting and Data System) to include contrast-enhanced ultrasound (CEUS)* imaging for hepatocellular carcinoma (HCC) characterization, the Aplio i-series offers an ideal solution for confident diagnoses.

Offering healthcare providers a more cost-effective, less invasive and safer solution than other radiation emitting modalities, the Aplio i-series is a highly-advanced and scalable ultrasound solution made up of the Aplio i700 and Aplio i800. Health systems, such as UC San Diego Health, are using the Aplio i-series’ imaging resolution and penetration, and comprehensive CEUS imaging and quantification package, to assess perfusion dynamics in the liver and help improve HCC surveillance results.

“The Aplio i-series offers the superb image quality clinicians need to make confident diagnosis and provide excellent patient care,” said Dan Skyba, director, Ultrasound Business Unit, Toshiba America Medical Systems, Inc. “Combining a brand new system architecture with matrix transducer technology and a world-renown CEUS imaging package, these premium systems offer best in class resolution, penetration and dynamic contrast visualization. The Aplio i-series facilitates small HCC diagnosis and surveillance, even in obese or difficult to image patients, while improving workflow and keeping patients safe and more comfortable. As the transition to a value-based healthcare system continues, the use of CEUS for characterization of focal liver lesions is an example of a cost-effective and high-value clinical solution.”

About Toshiba America Medical Systems, Inc.

Toshiba America Medical Systems, a Canon Group company headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment. For more information, visit Toshiba Medical’s website at www.medical.toshiba.com.

About Toshiba Medical

Toshiba Medical offers a full range of diagnostic medical imaging solutions including Ultrasound, CT, X-Ray, and MR, across the globe. As of December 2016, Toshiba Medical became a member of the Canon Group. In line with our continued Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide so that together our industry-leading solutions deliver an enriched quality of life.

*Using FDA approved contrast agent

Aplio is a trademark of Toshiba Medical Systems Corporation.